These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33309157)

  • 1. Different clinical presentations of subgenotype 2.1 strain of classical swine fever infection in weaned piglets and adults, and long-term cross-protection conferred by a C-strain vaccine.
    Wang Q; Liu H; Xu L; Li J; Wu H; Yang C; Chen X; Deng Y; Sun Y; Tu C; Chen N; Gong W; Chen G
    Vet Microbiol; 2021 Feb; 253():108915. PubMed ID: 33309157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China.
    Luo Y; Ji S; Lei JL; Xiang GT; Liu Y; Gao Y; Meng XY; Zheng G; Zhang EY; Wang Y; Du ML; Li Y; Li S; He XJ; Sun Y; Qiu HJ
    Vet Microbiol; 2017 Mar; 201():154-161. PubMed ID: 28284603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of a Moderately Virulent Classical Swine Fever Virus Emerging in China.
    Luo Y; Ji S; Liu Y; Lei JL; Xia SL; Wang Y; Du ML; Shao L; Meng XY; Zhou M; Sun Y; Qiu HJ
    Transbound Emerg Dis; 2017 Dec; 64(6):1848-1857. PubMed ID: 27658930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
    Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ
    J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel chimeric E2CD154 subunit vaccine is safe and confers long lasting protection against classical swine fever virus.
    Suárez-Pedroso M; Sordo-Puga Y; Sosa-Teste I; Rodriguez-Molto MP; Naranjo-Valdés P; Sardina-González T; Santana-Rodríguez E; Montero-Espinosa C; Frías-Laporeaux MT; Fuentes-Rodríguez Y; Pérez-Pérez D; Oliva-Cárdenas A; Pereda CL; González-Fernández N; Bover-Fuentes E; Vargas-Hernández M; Duarte CA; Estrada-García MP
    Vet Immunol Immunopathol; 2021 Apr; 234():110222. PubMed ID: 33690056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
    Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
    Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commercial E2 subunit vaccine provides full protection to pigs against lethal challenge with 4 strains of classical swine fever virus genotype 2.
    Gong W; Li J; Wang Z; Sun J; Mi S; Xu J; Cao J; Hou Y; Wang D; Huo X; Sun Y; Wang P; Yuan K; Gao Y; Zhou X; He S; Tu C
    Vet Microbiol; 2019 Oct; 237():108403. PubMed ID: 31585656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
    de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
    Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain.
    Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ
    Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain.
    Han Y; Xie L; Yuan M; Ma Y; Sun H; Sun Y; Li Y; Qiu HJ
    Vet Microbiol; 2020 Aug; 247():108741. PubMed ID: 32768202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping and Molecular Characterization of Classical Swine Fever Virus Isolated in China during 2016-2018.
    Fatima M; Luo Y; Zhang L; Wang PY; Song H; Fu Y; Li Y; Sun Y; Li S; Bao YJ; Qiu HJ
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of classical swine fever control: modified live and E2 subunit vaccines.
    Huang YL; Deng MC; Wang FI; Huang CC; Chang CY
    Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P108 and T109 on E2 Glycoprotein Domain I Are Critical for the Adaptation of Classical Swine Fever Virus to Rabbits but Not for Virulence in Pigs.
    Xie L; Han Y; Ma Y; Yuan M; Li W; Li LF; Li M; Sun Y; Luo Y; Li S; Hu S; Li Y; Qiu HJ
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.
    Eblé PL; Quak S; Geurts Y; Moonen-Leusen HW; Loeffen WL
    Vet Microbiol; 2014 Nov; 174(1-2):27-38. PubMed ID: 25265929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.
    Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A
    Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of chronic and persistent classical swine fever infections under field conditions and their impact on vaccine efficacy.
    Coronado L; Bohórquez JA; Muñoz-González S; Perez LJ; Rosell R; Fonseca O; Delgado L; Perera CL; Frías MT; Ganges L
    BMC Vet Res; 2019 Jul; 15(1):247. PubMed ID: 31307464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
    Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
    Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical swine fever in China: a minireview.
    Luo Y; Li S; Sun Y; Qiu HJ
    Vet Microbiol; 2014 Aug; 172(1-2):1-6. PubMed ID: 24793098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.